BioLargo Subsidiary Clyra Medical's Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study

Press/Media: Expert Comment

PeriodMay 19 2020

Media coverage

2

Media coverage

  • TitleBioLargo Subsidiary Clyra Medical's Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study
    Media name/outletIndia Pharma News
    CountryIndia
    Date5/19/20
    PersonsSlobodan Paessler
  • TitleBioLargo Subsidiary Clyra Medical's Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study
    Media name/outletFSCwire
    CountryCanada
    Date5/19/20
    PersonsSlobodan Paessler

Keywords

  • COVID-19